← Back to Newsletter Archive
Greetings!

Welcome to the Monthly QPS Clinical Newsletter


Explore the new QPS white paper on harnessing Real World Evidence to drive drug development, learn more about our clinical research services, and read the recent advancements and discoveries in science on the QPS blog.

Harnessing Real World Evidence: Drug Development Through Data Driven Insights

At QPS, we’re committed to advancing clinical research through innovative approaches that reflect real-life patient experiences. Real-world data (RWD) includes information gathered from everyday healthcare settings. When this data is analyzed to generate insights about treatment effectiveness, safety, and usage, it becomes real-world evidence (RWE).

QPS offers RWE clinical studies using RWD. This approach allows a better understanding of how therapies perform across diverse populations and in real-world conditions, ultimately helping our partners bring safer, more effective treatments to market faster.

Clinical Research Services

QPS supports every stage of clinical development with full Phase I–IV trial services. Our end-to-end support includes:

  • Phase I - IV Trials
  • First-in-Human Trials
  • Pharmacokinetics & Pharmacodynamics
  • Bioavailability & Bioequivalence
  • Drug-Drug Interaction (DDI) Studies
  • Food Effect Studies
  • Single & Multiple Dose Escalation (SAD/MAD)
  • Efficacy Endpoints
  • Bridging Studies
  • Basket Studies
  • Post-Marketing Studies
  • Real World Data (RWD) & Real World Evidence (RWE)

Contact QPS to Start Your Next Clinical Trial

Discover the Future of Science on the QPS Blog

Unanswered Questions: Mysterious Cluster of Brain Tumors Investigated at Massachusetts Hospital


Six nurses working on the fifth-floor maternity unit at Newton-Wellesley Hospital in Massachusetts have been diagnosed with benign brain tumors, sparking concern about a cancer cluster and prompting dual investigations by the hospital’s administration and...


What is a Cancer Cluster?

More Oncology Blog Posts

Creutzfeldt-Jakob Disease Outbreak Sparks Concern


Prion diseases are rapidly progressive, neurodegenerative disorders caused by infectious protein particles called prions. While these diseases can affect both humans and animals, they are quite rare. Creutzfeldt-Jakob disease (CJD) may be the best-known prion disease due to...


How Is CJD Transmitted?

Learn More about QPS Clinical Research Services

Visit our website www.qps.com 

or contact us at info@qps.com

for an appointment.

Linkedin  Youtube  X  Facebook  

www.qps.cominfo@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
← Back to Newsletter Archive